「code」の検索結果
20件：11～15件目を表示
-
sed to announce that “Avarept® Ophthalmic suspension 0.3%” (Generic Name: Motugivatrep, development code: SJP-0132, hereinafter: Product), discovered and licensed by Mochida Pharmaceutical Co., Ltd. (...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
n; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 antagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
n; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 antagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf -
Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
Code of Conduct for Compliance The directors, employees and other members of Senju Pharmaceutical Co., Ltd. (“SENJU”) will act in compliance not only with the law but will operate under a high standar...
https://www.senju.co.jp/english/about/csr03.html -
全球业务开展 | 海外活动 | 千寿制药株式会社
, World Financial Centre No.1, East 3rd Ring Middle Road, Chaoyang District, Beijing, P.R.C. Postal Code：100020 Tel：+86-10-6533-0200 Fax：+86-10-6536-1329 千寿制药科技（北京）有限公司中国，北京 1606A，16th Floor, West Tow...
https://www.senju.co.jp/chinese/global/